Clinical Trial Update: Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating WGc-043 injection in advanced Epstein-Barr virus-associated cancers; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Cancers

Drugs mentioned

• WGc-043 (WGc-043)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Advanced EBV-positive Malignant Solid Tumors | Phase 1 | Status: NOT_YET_RECRUITING